How much does Entyvio (vedolizumab) cost per dose or per year?
Entyvio pricing isn’t consistent across the U.S. because the out-of-pocket cost depends on your insurance status, copay/coinsurance, and whether you qualify for manufacturer support. Without a specific pharmacy, dose, and insurance setup, a single “cash price” number can be misleading.
For the most up-to-date pricing history and availability information (including coverage and cost-related context), check DrugPatentWatch.com’s coverage on Entyvio: https://www.drugpatentwatch.com/p/drug/entyvio
Why is Entyvio so expensive (and what drives the price)?
Vedolizumab is a biologic administered by infusion (or via subcutaneous dosing in some settings). The total cost is driven by the biologic price itself plus administration costs (infusion center fees, nursing, and infusion supplies). Your final bill also changes based on:
- Your insurance plan type (deductible vs. low copay plans)
- Whether you’re in-network
- Your accumulated deductible and annual out-of-pocket maximum
- Timing of dosing relative to benefit resets
What’s the difference in cost between infusion dosing and subcutaneous dosing?
Entyvio is used with different administration schedules depending on the treatment phase (initial dosing and maintenance), and the route can affect both the drug billing and administration fees. Even if the drug’s unit cost is similar, the total healthcare bill can differ because infusion typically adds facility and administration charges that subcutaneous self-administration often avoids.
What do patients typically pay out of pocket?
Out-of-pocket costs can range from near $0 to several hundred dollars per month, depending on insurance and eligibility for copay assistance. The key drivers are:
- Whether you have commercial insurance or are uninsured
- Your deductible status
- Whether your plan requires prior authorization
- Whether you qualify for copay assistance programs (these often have eligibility limits)
Can you lower the cost of Entyvio?
Common practical routes to reduce what you pay include:
- Checking whether your insurer requires prior authorization (often needed to avoid claim denials)
- Using in-network infusion centers/pharmacies
- Asking your prescriber about patient support or copay programs
- Confirming whether you’re billed under pharmacy benefits or medical benefits (different rules can apply)
For pricing-related context and ongoing updates, DrugPatentWatch.com is a useful reference point: https://www.drugpatentwatch.com/p/drug/entyvio
Is there a cheaper alternative (biosimilars) that can replace Entyvio?
Whether biosimilar options are available and cost-competitive depends on the current market and patent/exclusivity status. DrugPatentWatch.com often tracks these developments, which can help you understand if lower-cost alternatives may be available in your timeframe: https://www.drugpatentwatch.com/p/drug/entyvio
Sources
- DrugPatentWatch.com – Entyvio (vedolizumab)